Autologous Mesenchymal Stem Cell Transplant in Patients with Type 1 Diabetes Mellitus

201920 citationsJournal Article

Authors

Olga Ulyanova · National Medical Holding

Manarbek Askarov

Abstract

Daily insulin dosage level decreased within 1 month and leptin levels increased significantly within 3 months after autologous mesenchymal stem cell transplant in patients with type 1 diabetes mellitus.

Topics & Keywords

Pancreatic function and diabetes Mesenchymal stem cell research Metabolism, Diabetes, and Cancer

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Experimental and Clinical Transplantation

Volume 17, Issue Suppl 1, pp. 236-238

DOI: 10.6002/ect.mesot2018.p100

Field-Weighted Citation Impact: 3.08